APA aipamena

Berlin, J. D., Feng, Y., Catalano, P., Abbruzzese, J. L., Philip, P. A., McWilliams, R. R., . . . Blackstock, A. W. (2017). An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A trial of the ECOG-ACRIN Cancer Research Group (E2204). Oncology.

Chicago Style aipamena

Berlin, Jordan D., Yang Feng, Paul Catalano, James L. Abbruzzese, Philip A. Philip, Robert R. McWilliams, Andrew M. Lowy, Al B. Benson, and A. William Blackstock. "An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination With Gemcitabine and in Combination With Chemoradiation in Patients With Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)." Oncology 2017.

MLA aipamena

Berlin, Jordan D., et al. "An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination With Gemcitabine and in Combination With Chemoradiation in Patients With Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)." Oncology 2017.